openPR Logo
Press release

Global Spinal Cord Injury Pipeline Market 2021, Key Players Analysis Kringle Pharma, Eusol Biotech, Pharmicell, Pharmazz, AbbVie, Acorda Therapeutics, Geron Corporation, ReNetX Bio, GNT Pharma

09-07-2021 02:41 PM CET | Health & Medicine

Press release from: ReportsnReports

Spinal Cord Injury Pipeline Market Insight, 2021 report provides comprehensive insights about 35+ companies and 35+ pipeline drugs in Spinal Cord Injury pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Geography Covered
- Global coverage

Get a Free Sample Copy of Global Spinal cord injury Pipeline Market Research Report at https://www.reportsnreports.com/contacts/requestsample.aspx?name=4513300

Spinal Cord Injury Understanding
Spinal Cord Injury: Overview
Spinal Cord Injury (SCI) is a condition in which damage to any part of the spinal cord or nerves at the end of the spinal canal (cauda equina) occurs. Spinal Cord Injury can be traumatic or non-traumatic. The symptoms of SCI will depend on the type (complete or incomplete) and location of the damage and includes weakness in the arms and/or legs, difficulty breathing, severe pain or pressure in the neck or back, decreased sensation in the arms and/or legs, unusual lumps along the spine, and loss of bladder or bowel control. A diagnosis of SCI is based upon a medical history, physical examination, and testing for sensory function and movement. Tests may include X-rays, Computerized tomography (CT) scan, and Magnetic resonance imaging (MRI). Treatments for SCI includes surgery, medication and physical therapy. The primary aid or measures should be taken immediately to minimize the injury. Corticosteroid injections may help in spinal cord injuries.

"Spinal Cord Injury - Pipeline Insight, 2021" report outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Spinal Cord Injury pipeline landscape is provided which includes the disease overview and Spinal Cord Injury treatment guidelines. The assessment part of the report embraces, in depth Spinal Cord Injury commercial assessment and clinical assessment of the pipeline products under development. In the report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Spinal Cord Injury collaborations, licensing, mergers and acquisition, funding, designations and other product related details.

Report Highlights
- The companies and academics are working to assess challenges and seek opportunities that could influence Spinal Cord Injury R&D. The therapies under development are focused on novel approaches to treat/improve Spinal Cord Injury.

Get 20% and More Discount on Global Spinal cord injury Pipeline Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=4513300

Spinal Cord Injury Emerging Drugs Chapters
This segment of the Spinal Cord Injury report encloses its detailed analysis of various drugs in different stages of clinical development, including phase III, II, I, preclinical and Discovery. It also helps to understand clinical trial details, expressive pharmacological action, agreements and collaborations, and the latest news and press releases.

Spinal Cord Injury Emerging Drugs
- ES 135: Eusol Biotech
ES135 is a recombinant human acidic fibroblast growth factor (rhFGF1) with 135 amino acids. ES135 promote neurite outgrowth. The sequence of ES135 has been patented in Taiwan, EU, China and the United States. ES135 is undergoing a Phase 3 clinical trial for spinal cord injury treatment.

- MT-3921: Mitsubishi Tanabe Pharma Corporation
MT 3921 is a humanized immunoglobulin G1 (IgG1) anti- RGMa antibody. In July 2021, MT 3921 receives Fast Track designation for Spinal cord injuries [IV] (In the elderly, adults). The therapy is currently under Phase II clinical development for the treatment of Spinal Cord Injury.
Further product details are provided in the report……..

Spinal Cord Injury: Therapeutic Assessment
This segment of the report provides insights about the different Spinal Cord Injury drugs segregated based on following parameters that define the scope of the report, such as:
- Major Players in Spinal Cord Injury
There are approx. 35+ key companies which are developing the therapies for Spinal Cord Injury. The companies which have their Spinal Cord Injury drug candidates in the most advanced stage, i.e. Phase III include, Eusol Biotech.

- Phases
The report covers around 35+ products under different phases of clinical development like
- Late stage products (Phase III)
- Mid-stage products (Phase II)
- Early-stage product (Phase I) along with the details of
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates

For More Details Inquire at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=4513300

- Route of Administration
Spinal Cord Injury pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
- Oral
- Parenteral
- Intravitreal
- Subretinal
- Topical

- Molecule Type
Products have been categorized under various Molecule types such as
- Monoclonal Antibody
- Peptides
- Polymer
- Small molecule
- Gene therapy

- Product Type
Drugs have been categorized under various product types like Mono, Combination and Mono/Combination.

Spinal Cord Injury: Pipeline Development Activities
The report provides insights into different therapeutic candidates in phase III, II, I, preclinical and discovery stage. It also analyses Spinal Cord Injury therapeutic drugs key players involved in developing key drugs.

Pipeline Development Activities
The report covers the detailed information of collaborations, acquisition and merger, licensing along with a thorough therapeutic assessment of emerging Spinal Cord Injury drugs.

Spinal Cord Injury Report Insights
- Spinal Cord Injury Pipeline Analysis
- Therapeutic Assessment
- Unmet Needs
- Impact of Drugs

Spinal Cord Injury Report Assessment
- Pipeline Product Profiles
- Therapeutic Assessment
- Pipeline Assessment
- Inactive drugs assessment
- Unmet Needs

Key Questions
Current Treatment Scenario and Emerging Therapies:
- How many companies are developing Spinal Cord Injury drugs?
- How many Spinal Cord Injury drugs are developed by each company?
- How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Spinal Cord Injury?
- What are the key collaborations (Industry-Industry, Industry-Academia), Mergers and acquisitions, licensing activities related to the Spinal Cord Injury therapeutics?
- What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
- What are the clinical studies going on for Spinal Cord Injury and their status?
- What are the key designations that have been granted to the emerging drugs?

Direct Purchase of Global Spinal cord injury Pipeline Market Research Report at https://www.reportsnreports.com/purchase.aspx?name=4513300

Key Players
- Kringle Pharma
- Eusol Biotech
- Pharmicell
- Pharmazz
- AbbVie
- Acorda Therapeutics
- Geron Corporation
- ReNetX Bio
- GNT Pharma
- AlaMab Therapeutics
- Mitsubishi Tanabe Pharma
- Kancera
- Olatec Therapeutics
- Scholar Rock
- AXONIS Therapeutics
- K-STEMCELL
- Nordic Life Science Pipeline
- NervGen Pharma
- Athersys
- Healios
- Angiocrine Bioscience

Key Products
- Hepatocyte growth factor
- ES 135
- Autologous mesenchymal stem cell therapy
- Sovateltide
- Elezanumab
- Fampridine sustained release
- OPC 1
- AXER-204
- Nelonemdaz
- ALMB 0166
- MT-3921
- KAND 567
- Dapansutrile
- Apitegromab
- AAV gene therapy
- Stem cell therapies
- Spinalon
- NVG 291
- Invimestrocel
- AB-225

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

+ 1 888 391 5441
sales@reportsandreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Spinal Cord Injury Pipeline Market 2021, Key Players Analysis Kringle Pharma, Eusol Biotech, Pharmicell, Pharmazz, AbbVie, Acorda Therapeutics, Geron Corporation, ReNetX Bio, GNT Pharma here

News-ID: 2384511 • Views: 195

More Releases from ReportsnReports

Neodecanoic Acid Market 2021 | Detailed Report
According to Market Study Report, Neodecanoic Acid Market provides a comprehensive analysis of the Neodecanoic Acid Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. Get Free Sample PDF (including full TOC, Tables and Figures) of Neodecanoic Acid Market: https://www.reportsnreports.com/contacts/requestsample.aspx?name=4099082 #Key Players- - Shell - ExxonMobil Chemical - Haihang Industry Co., Ltd. - JH Chemical - Mobil Neodecanoic Acid Market segment by Type: - Analysis Grade - Industrial Grade Neodecanoic Acid Market
Nano Crystalline Cellulose Market 2021 | Detailed Report
According to Market Study Report, Nano Crystalline Cellulose Market provides a comprehensive analysis of the Nano Crystalline Cellulose Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. Get Free Sample PDF (including full TOC, Tables and Figures) of Nano Crystalline Cellulose Market: https://www.reportsnreports.com/contacts/requestsample.aspx?name=4099115 #Key Players- - FMC Corporation - Sigachi Industrial - Asahi Kasei Corporation - Avantor Performance Materials Nano Crystalline Cellulose Market segment by Type: - Sulfuric Acid
Gynecological Specula Market 2021 | Detailed Report
According to Market Study Report, Gynecological Specula Market provides a comprehensive analysis of the Gynecological Specula Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. Get Free Sample PDF (including full TOC, Tables and Figures) of Gynecological Specula Market: https://www.reportsnreports.com/contacts/requestsample.aspx?name=4099009 #Key Players- - Adlin (Brasil) - CooperSurgical (USA) - DTR Medical (UK) - Entrhal Medical (Germany) - Evexar Medical (UK) - Faromed Medizintechnik (Germany) - FASA GROUP (Germany) - J&J Instruments
Hologram Projector Market 2021 | Detailed Report
According to Market Study Report, Hologram Projector Market provides a comprehensive analysis of the Hologram Projector Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. Get Free Sample PDF (including full TOC, Tables and Figures) of Hologram Projector Market: https://www.reportsnreports.com/contacts/requestsample.aspx?name=4099081 #Key Players- - Holo2GO - Musion - MDH - Dreamoc - Holus Pro - Holho - LANMU - 3D HOLOGRAM - Majix.Tech - Shenzhen Wiikk Technology - GIWOX - Wootclub - Prosmart - HOLOMOX - VIRTUAL ON LTD -

All 5 Releases


More Releases for Spinal

Spinal Non-Fusion
Spinal implants are devices used for the treatment of spinal disorders such as disproportion and instability of spine. Spine surgical devices are broadly classified into fusion and non-fusion devices. Fusion devices heals by providing immediate and rigid immobilization, and non-fusion devices treats by replacing pro-inflammatory tissues, restoring spinal alignment, and decompressing neural elements while preserving functional movements rather than obliterating it. The advantages such as prolonged recuperation time, bone graft
Spinal Trauma Devices Market: Spinal Trauma Devices Sales to Surge Rapidly in Re …
The global spinal trauma devices market is dynamic and highly competitive. Only a couple of companies account for a substantial share in the market, thus lending it an oligopolistic vendor landscape. The market is largely dominated by DePuy Synthes, Medtronic, NuVasive, Inc., Stryker Corporation, and Globus Medical, Inc. The cumulative share of these companies added up to 79.1% in 2014, says Transparency Market Research (TMR) in a new report. As
Global Spinal Fusion Market Research Report 2017
This report studies Spinal Fusion in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Trauson Depuy Synthes Companies Biomet Medtronic Nuvasive Stryker Corporation Zimmer Orthofix International N.V B. Braun Aesculap Weigao Orthopaedic Invibio MicroPort Biocomposites SCIENT’X Request Sample Report: http://www.reportbazzar.com/request-sample/?pid=887312&ptitle=Global+Spinal+Fusion+Market+Research+Report+2017&req=Sample Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Spinal
Spinal Fusion - Current and Future Players
ReportsWorldwide has announced the addition of a new report title Spinal Fusion - Current and Future Players to its growing collection of premium market research reports. The spinal fusion market is an established orthopedic market that has witnessed sluggish revenue growth in the past five years. GlobalData evaluated the currently-marketed spinal fusion implants, identified the unmet needs in the market, and provided an understanding of surgeons’ perceptions of the latest advances,
Spinal Fusion - Europe Analysis and Market Forecasts
ReportsWorldwide has announced the addition of a new report title Spinal Fusion - Europe Analysis and Market Forecasts to its growing collection of premium market research reports. The spinal fusion market is an established orthopedic market that has witnessed sluggish revenue growth in the past five years. GlobalData evaluated the currently-marketed spinal fusion implants, identified the unmet needs in the market, and provided an understanding of surgeons’ perceptions of the latest
Global Spinal Implants Sales Market Report 2021
Global Spinal Implants Industry 2016 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2016-2020. The market intelligence publication delves into the condition of the global Spinal Implants market. An in-depth examination of the existing market state, past progress, and forthcoming prospects of the global Spinal Implants market has been presented in the research report. The research publication also reports the chief strategies,